U.S. District Judge Joseph Goodwin said that it could take decades and cost millions of dollars in fees to try the more than 70,000 transvaginal mesh lawsuits that have been filed against seven pharmaceutical companies. Goodwin has urged the device makers and the claimants to work harder to resolve one of the biggest U.S. mass torts in history, but has vowed to send the suits to trial if need be.
Thousands of women have claimed the transvaginal mesh devices, which are used to treat stress urinary incontinence and pelvic organ prolapse, have caused painful infections, bleeding and other complications.
Intensive court-supervised meetings between key defendants Boston Scientific Corp, C.R. Bard and Johnson & Johnson’s Ethicon Inc. and lawyers for the women have led to no resolutions.
Bard, Ethicon and Boston Scientific have had the most claims filed against them, and have each been hit with multimillion dollar verdicts that have increased the pressure to settle. The companies, however, are standing behind their devices, denying all claims that they are defective. Lawyers for the three main companies are ready to prepare hundreds of additional cases for trial if need be.
Not all of the device makers are pushing for trials. American Medical Systems, a subsidiary of Endo International Plc, has already decided to settle, setting aside $1.6 billion to resolve 20,000 lawsuits. Danish company Coloplast A/S has also settled a sizeable amount of the nearly 2,000 mesh lawsuits brought against it.
If you or a loved one has suffered from infection, bleeding, or other side effects of a transvaginal mesh device, you may be able to seek medical compensation. Click here to receive a free case evaluation.
Latest posts by CitizensReport (see all)
- Good Sugar, Bad Sugar: Why You Should Eat More Fruit - June 16, 2017
- Safety Reminders For Blood Sugar Testing - June 2, 2017
- 4 Tips for Treating Migraines - May 5, 2017